Templos-Esteban LA, Delgado-Carlo MM

Language: Spanish
References: 14
Page: 172-178
PDF size: 80.04 Kb.

ABSTRACT

Objective: The postoperatory analgesia in the obstetric patient is controversial for the adverse effects that can happen with the elimination of medicaments in the breast milk. One must find a suitable line of managing, which can be provided by the peridural opioids. Material and methods: 60 patients submitted to Caesarean, 30 for the group A (peridural morphine) and 30 for the group B (peridural buprenorphine). Administering 2 mg of morphine or 300 mg of buprenorphine in the moment of the cut the umbilical cord, realizing measurements of the Visual Analogous Scale and adverse effects: nausea, vomit, pruritus, urinary retention and Ramsay to the moment of revenue to recovery, at 2, 4, 6, 12 and 24 h. Results: The group of morphine was top for presenting at 12 h, 56% of the patients with minor EVA of 5. One presented pruritus in 14% of the patients of the group A and nausea in 14% of the patients of the group B only to his revenue to recovery. Conclusions: The epidural morphine was effective for 8 to 12 h in average but not sufficiently in the only dose for the control of postoperatory pain. Analgesia of rescue was needed.

REFERENCES

1. Covarrubias A, Silva A, Nuche E, Téllez E. El manejo del dolor postoperatorio en obstetricia: ¿Es seguro? Rev Mex Anest 2006;29:231-239.

2. Olguín M. Analgesia postcesárea: opioides neuroaxiales, vía de elección. Rev Chilen Anest 2002;31:1-3.

3. Bartha E, Dualé C, Frey F, Bolandard A, Schoeffler PB. Evaluation of cost and effects of epidural analgesia and patient controlled intravenous analgesia after major abdominal surgery. B J Anaesth 2006;96:111-117.

4. Jaime A. Analgesia postcesárea con sulfato de morfina en infusión epidural. Rev Mex Anest 1999;22:238-242.

5. Villegas M, Segura G, Acevedo J. Comparación de la incidencia de prurito en las primeras 24 horas de postoperatorio cuando se utiliza morfina e hidromorfina peridurales como analgésicos para la operación cesárea. Rev Col Anest 2001;XXIX:2:155-162.

6. Bernards CM, Shen D, Sterling S, Pharm D, Adkins J, Risler LS, Phillips B, Ummenhofer W. Epidural, cerebrospinal fluid and pharmacokinetics epidural opioids (part 2): effect of epinephrine. Anesth 2003;99:466-475.

7. Yukitoshi N, Tomoyuki N, Hitoshi S, Keiilchi O, Akiyoshi N. The addition of epidural morphine to ropivacaine improves epidural analgesia after lower abdominal surgery. Can J Anesth 2005;52:181-185.

8. Rojas RA, Mendoza ME, Gutiérrez E, Velasco S, Murguía Y. Buprenorfina epidural vs Bupivacaína al 0.125% para el manejo de dolor en la paciente postoperada de cesárea. Rev Mex Anest 2001;1(2):112-115.

9. Zaldívar VM, Ríos AV. Buprenorfina en el período postoperatorio vía peridural y sublingual: analgesia y efectos colaterales. Rev Mex Anest 2003;26(3):145-147.

10. Coda BA. Opioides. En: Barash PG. Anestesia Clínica. Editorial Mc Graw-Hill Interamericana. Tercera edición. Tomo I:389-424.

11. Committee on Drugs. The transfer of drugs and other chemicals in to human milk. Pediatrics 2001;108:776-789.

12. Chestnut DH. Efficacy and safety opioids for postoperative analgesia. Anesth 2005;102:221-223.

13. Gómez JJ, Godínez H. Analgesia perioperatoria peridural. Infusión vs analgesia única en el perioperatorio en la operación cesárea. Rev Mex Anest 2003;26(4):194-197.

14. Pan P, Coghill R, Houle T, Seid M, Lindel W, Parker, Washburn S, Harris L, Eisenach J. Multifactorial preoperative predictors for postcaesarean section pain and analgesic requirement. Anesth 2006;104(3):417-425.